Company intelligence / Profile preview

First Ascent Biomedical

Miami, Florida, United Statesfirstascentbiomedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

First Ascent Biomedical’s AI-driven functional precision medicine platform integrates ex vivo drug sensitivity testing, DNA/RNA sequencing, and machine learning to generate individualized treatment plans for advanced cancer patients. In published results, patients treated based on the platform had an 83% greater benefit than those treated with standard of care physician choice therapies.

Therapeutic areas: Oncology
Modalities: Small moleculeBiologicCombination therapy
Industry: Molecular Diagnostics

Partnerships

Fight Colorectal Cancer Foundation ("Fight CRC")Gannon University/Saint Vincent HospitalChampions OncologyRoche Genentech

Beyond the preview

Go deeper on First Ascent Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Ascent Biomedical.

Explore the full profile